{"database":"GEO","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE349nnn/GSE349074/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Transcriptomics"],"species":["Homo sapiens"],"gds_type":["Expression profiling by RT-PCR"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE349074"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"Gene Expression Dataset of Tazemetostat-Treated SW-1736 Cells Using the WNT Signaling RT² Profiler PCR Array","description":"This study evaluates the transcriptional response of human anaplastic thyroid carcinoma SW-1736 cells to the EZH2 inhibitor tazemetostat, with emphasis on WNT signaling pathway-related gene expression. SW-1736 cells were treated with 33.90 µM tazemetostat for 24, 48, and 72 hours. Total RNA was isolated, converted to cDNA, and analyzed using the Qiagen RT² Profiler PCR Array Human WNT Signaling Pathway (PAHS-043Z) on a Roche LightCycler 480 Real-Time PCR System.","dates":{"publication":"2026/09/29"},"accession":"GSE349074","cross_references":{"GSM":["GSM10086629","GSM10086631","GSM10086632","GSM10086630"],"GPL":["37601"],"GSE":["349074"],"taxon":["Homo sapiens"]}}